Yini i-Inebilizumab: Ukusetshenziswa, Umthamo, Imiphumela Eceleni Nokunye

I-Inebilizumab iyimithi ekhethekile eyenzelwe ukwelapha i-neuromyelitis optica spectrum disorder (NMOSD), isimo esingavamile sokuzivikela komzimba esihlasela imizwa yamehlo kanye nomgogodla. Le mithi isebenza ngokugxila kumaseli athile omzimba okuthiwa ama-B cells abamba iqhaza ekuvuvukeni nasekulimaleni okubonakala ku-NMOSD.

Uma wena noma othile omkhathalelayo etholiwe ukuthi une-NMOSD, cishe uzizwa ukhungathekile ngenxa yobunzima balesi simo. Ukuqonda izinketho zakho zokwelapha, okuhlanganisa i-inebilizumab, kungakusiza ukuthi uzizwe uqiniseka ngokwengeziwe ngokuphatha lokhu kuxilongwa okuyinselele.

Yini i-Inebilizumab?

I-Inebilizumab iyimithi ye-monoclonal antibody esiza ukulawula i-neuromyelitis optica spectrum disorder ngokugxila ohlelweni lwakho lokuzivikela komzimba. Yenzelwe ngokuqondile ukubopha kuma-CD19-positive B cells, okuyizicubu zomzimba ezidlala indima ebalulekile ekuhlaselweni komzimba okuzenzakalelayo okubonakala ku-NMOSD.

Le mithi ingeyeqembu lemithi ebizwa ngokuthi ama-immunosuppressants, okusho ukuthi inciphisa umsebenzi wakho wokuzivikela komzimba. Nakuba lokhu kungase kuzwakale kukhathaza, empeleni kuyasiza ku-NMOSD ngoba uhlelo lwakho lokuzivikela komzimba ngokungaqondile luhlasela izicubu ezinempilo ohlelweni lwakho lwezinzwa.

Umuthi unikezwa njenge-intravenous infusion, okusho ukuthi ulethwa ngokuqondile emgudwini wakho wegazi ngomthambo. Le ndlela iqinisekisa ukuthi imithi ifinyelela ezindaweni ezifanele emzimbeni wakho lapho ingasebenza kahle khona.

Isetshenziselwani i-Inebilizumab?

I-Inebilizumab isetshenziswa ikakhulukazi ukwelapha abantu abadala abane-neuromyelitis optica spectrum disorder (NMOSD). I-NMOSD yisimo esingavamile sokuzivikela komzimba lapho uhlelo lwakho lokuzivikela komzimba luhlasela ikhava evikelayo ezungeze imizwa yakho yamehlo kanye nomgogodla, okubangela ukuvuvukala nokulimala.

Lo muthi uvunyelwe ngqo kubantu abahlolwa ukuthi banama-antibody e-aquaporin-4 (AQP4), atholakala cishe kuma-70-80% abantu abane-NMOSD. Lawa ma-antibody afana nezimpawu ze-molecular ezisiza odokotela ukuqinisekisa ukuxilongwa futhi babike ukuthi lesi sifo singahamba kanjani.

Umgomo oyinhloko wokwelashwa nge-inebilizumab ukuvimbela ukuphindeka noma ukuhlaselwa kwe-NMOSD. Ngesikhathi sokuphindeka, ungezwa izimpawu ezinjengokulahlekelwa umbono, ubuthakathaka, ukuqaqamba, noma izinkinga ngomsebenzi wesinye namathumbu. Ngokunciphisa imvamisa yalokhu kuhlaselwa, i-inebilizumab isiza ukugcina umsebenzi wakho we-neurological kanye nekhwalithi yempilo.

Isebenza Kanjani I-Inebilizumab?

I-Inebilizumab isebenza ngokugxila nasekuqothuleni amaseli e-CD19-positive B ohlelweni lwakho lomzimba lokuzivikela. Amaseli e-B amangqamuzana amhlophe egazi ngokuvamile asiza ukulwa nezifo, kodwa ku-NMOSD, anegalelo ekuhlaselweni kwe-autoimmune ohlelweni lwakho lwezinzwa.

Cabanga ngohlelo lwakho lomzimba lokuzivikela njengeqembu lezokuphepha eliqinile elihlasela umzimba wakho ngempela. I-Inebilizumab isebenza njengomphathi okhipha ngqo onogada bezokuphepha (amaseli e-B) abenza inkinga enkulu, kuyilapho eshiya ezinye izingxenye zomzimba wakho wokuzivikela zilungile.

Lokhu kuthathwa njengomuthi oqinile okhubaza ukuzivikela komzimba. Iqondiswe kakhulu kunezinye izikhubazi zokuzivikela ezindala, okusho ukuthi ingasebenza ngenkathi ingase ibangele imiphumela emibi embalwa kunezidakamizwa ezikhubaza ukuzivikela komzimba.

Umuthi uhlala ohlelweni lwakho izinyanga eziningana ngemuva kokufakwa ngakunye, unikeza ukuvikelwa okuqhubekayo ekuphindekeni kwe-NMOSD. Abantu abaningi badinga ukufakwa njalo ezinyangeni eziyisithupha ukuze bagcine lo mphumela wokuvikela.

Kufanele Ngiyithathe Kanjani I-Inebilizumab?

I-Inebilizumab inikezwa njengokufakwa ngomthambo esikhungweni sezokwelapha, ngokuvamile esibhedlela noma esikhungweni sokufaka. Awukwazi ukuthatha lo muthi ekhaya, njengoba kudinga ukuqapha ngokucophelela ochwepheshe bezempilo ngesikhathi sokuphatha.

Ngaphambi kokufakwa ngakunye, ngokuvamile uzothola imithi yangaphambi kokwelashwa ukusiza ukuvimbela ukusabela kokufakwa. Lokhu kungabandakanya ama-antihistamines afana ne-diphenhydramine (Benadryl) kanye nama-corticosteroids afana ne-methylprednisolone. Ithimba lakho lokunakekelwa kwezempilo lizokunika le mithi cishe imizuzu engama-30-60 ngaphambi kokufakwa kwakho kwe-inebilizumab.

Ukufakwa ngokwako kuthatha cishe imizuzu engama-90 ngomthamo wokuqala kanye nemizuzu engama-60 ngemithamo elandelayo. Uzohlala kahle ngalesi sikhathi, futhi abahlengikazi bazobheka izimpawu zakho ezibalulekile futhi baqaphele noma yiziphi izimpawu zokuphendula.

Akudingeki ukuthi ulandele noma yikuphi ukudla okukhethekile ngaphambi noma ngemuva kokufakwa kwakho. Kodwa-ke, kungumqondo omuhle ukudla ukudla okulula ngaphambi kokuza ekuqokweni kwakho futhi uhlale unamanzi kahle. Abanye abantu bakuthola kuwusizo ukuletha incwadi, ithebhulethi, noma eminye imisebenzi ethule yokudlulisa isikhathi ngesikhathi sokufakwa.

Kufanele Ngiyithathe Isikhathi Esingakanani I-Inebilizumab?

I-Inebilizumab ngokuvamile iyindlela yokwelapha yesikhathi eside ye-NMOSD, futhi abantu abaningi baqhubeka beyithatha unomphela ukuvimbela ukuphindeka. Ubude bokwelashwa busekelwe ekutheni usabela kahle kangakanani emuthini nokuthi ngabe uhlangabezana nanoma yimaphi imiphumela emibi ebalulekile.

Abantu abaningi baqala ngokufakwa okubili kokuqala okunikezwa ngamaviki amabili ahlukene, kulandelwe ukufakwa kokugcinwa njalo ezinyangeni eziyisithupha. Udokotela wakho uzoqapha isimo sakho ngokucophelela ngonyaka wokuqala ukuhlola ukuthi umuthi usebenza kahle kangakanani kuwe.

Abanye abantu bangase bakwazi ukuhlukanisa ukufakwa kwabo uma behlala bezinzile futhi bengenakuphindeka isikhathi eside. Kodwa-ke, ukuyeka umuthi ngokuphelele kuvame ukuholela ekubuyeni komsebenzi wesifo, ngakho-ke abantu abaningi badinga ukuqhubeka nokwelashwa isikhathi eside.

Ithimba lakho lokunakekelwa kwezempilo lizohlola njalo ukusabela kwakho ekwelashweni kanye nanoma yimiphumela emibi ongase uhlangabezane nayo. Bazokusiza ukuthi ulinganise izinzuzo zokuqhubeka nokwelashwa ngokumelene nanoma yiziphi izingozi noma izinselelo ongase ubhekane nazo.

Ziyini Imiphumela Eceleni ye-Inebilizumab?

Njengayo yonke imithi, i-inebilizumab ingabangela imiphumela emibi, nakuba abantu abaningi beyibekezelela kahle. Ukuqonda ukuthi okulindeleke kungakusiza ukuthi uqaphele ukusabela okuvamile uma kuqhathaniswa nezimpawu ezikhathazayo ezidinga ukunakwa ngokushesha.

Imiphumela emibi evame kakhulu ongase uyithole ihlanganisa:

• Ukutheleleka ngamathumbu omchamo (UTIs)
• Ubuhlungu emalungeni noma i-arthralgia
• Ukusabela kokufakwa njengomkhuhlane, ama-chills, noma ukuqubuka
• Ubuhlungu emhlane
• Ukukhathala
• Ikhanda
• Isiyezi

Ukusabela kokufakwa mhlawumbe yikhona okukhathaza kakhulu ngesikhathi sokwelashwa. Lokhu kuvame ukwenzeka ngesikhathi noma ngemva nje kokufakwa futhi kungahlanganisa izimpawu ezinjengomkhuhlane, ama-chills, isicanucanu, ikhanda, noma ukuqubuka kwesikhumba. Ithimba lakho lezempilo lilungiswe kahle ukulawula lezi zimo uma zenzeka.

Imiphumela emibi engathi sína kodwa engavamile ingahlanganisa ukutheleleka okukhulu, ngoba i-inebilizumab icindezela amasosha akho omzimba. Ungase ube sengozini enkulu yokutheleleka ngamagciwane, amagciwane, noma isikhunta, ikakhulukazi emgudwini wokuphefumula noma ohlelweni lomchamo.

Ngokungavamile kakhulu, abanye abantu bangase bathole ukuvuselelwa kwamagciwane alala njenge-hepatitis B noma bathuthukise ukutheleleka kobuchopho okungathi sína okubizwa ngokuthi i-progressive multifocal leukoencephalopathy (PML). Udokotela wakho uzohlola lezi zingozi ngaphambi kokuqala ukwelashwa futhi akuqaphele ngokucophelela kuyo yonke inkambo yakho yokwelashwa.

Ubani Ongafanele Athole I-Inebilizumab?

I-Inebilizumab ayifanele wonke umuntu one-NMOSD. Udokotela wakho uzohlola ngokucophelela umlando wakho wezokwelapha kanye nesimo sakho sempilo yamanje ngaphambi kokuncoma lokhu kwelashwa.

Akufanele uthathe i-inebilizumab uma unokutheleleka okusebenzayo, okungathi sína okungelashwanga futhi okuxazululiwe. Lokhu kuhlanganisa ukutheleleka ngamagciwane njenge-pneumonia, ukutheleleka ngamagciwane njenge-hepatitis B, noma ukutheleleka ngesikhunta okungase kube kubi ngokucindezelwa komzimba.

Abantu abanomlando wokutheleleka nge-hepatitis B badinga ukucatshangelwa okukhethekile, njengoba i-inebilizumab ingabangela ukuthi leli gciwane liphinde lisebenze. Udokotela wakho uzohlola i-hepatitis B ngaphambi kokuqala ukwelashwa futhi angase ancome imithi elwa namagciwane uma kudingeka.

Uma ukhulelwe noma uhlela ukukhulelwa, i-inebilizumab ayinconyelwe. Lo muthi ungangena ngaphakathi esiswini futhi ungase uthinte amasosha omzimba engane yakho esakhula. Abesifazane abaneminyaka yokuzala kufanele basebenzise izindlela zokuvimbela inzalo ezisebenzayo ngesikhathi sokwelashwa kanye nezinyanga eziyisithupha ngemuva komthamo wokugcina.

Abantu abanezinhlobo ezithile zomdlavuza, ikakhulu umdlavuza wegazi, kungenzeka bangabi ngabantu abafanelekayo i-inebilizumab. Udokotela wakho uzohlola umlando wakho womdlavuza nesimo samanje lapho ecabangela le ndlela yokwelapha.

Igama Lomkhiqizo le-Inebilizumab

I-Inebilizumab ithengiswa ngaphansi kwegama lomkhiqizo elithi Uplizna e-United States. Leli igama lezentengiso ozolibona emuthini wakho kanye nasephaketheni lemithi.

Igama eliphelele elivamile lithi inebilizumab-cdon, lapho i-

I-Eculizumab (Soliris) ngomunye umuthi ovunywe yi-FDA we-NMOSD osebenza ngendlela ehlukile kune-inebilizumab. Esikhundleni sokuhlasela amaseli e-B, ivimba ingxenye yesistimu yokugcwalisa, okuyingxenye yesistimu yokuzivikela komzimba ebandakanyeka ku-NMOSD.

I-Satralizumab (Enspryng) iyindlela entsha ehloselwe i-interleukin-6, iphrotheni ekhuthaza ukuvuvukala. Inganikezwa njengesijovo esingaphansi kwesikhumba, okuyinto abanye abantu abayithandayo ngaphezu kokufakwa ngemithambo.

Imithi yendabuko ecindezela amasosha omzimba efana ne-azathioprine, i-mycophenolate mofetil, noma ama-corticosteroids nayo ingasetshenziswa, ikakhulukazi uma imithi emisha ingatholakali noma ingafaneleki esimweni sakho.

Ingabe i-Inebilizumab Ingcono Kune-Rituximab?

Kokubili i-inebilizumab ne-rituximab kuyizindlela zokwelapha eziphumelelayo ze-NMOSD, kodwa zinezinye izinto ezibalulekile ezingenza enye ifaneleke kakhulu esimweni sakho esithile.

I-Inebilizumab inenzuzo yokuthi ivunywe ngqo yi-FDA ye-NMOSD, okusho ukuthi idlule ekuvivinyweni komtholampilo okuqinile ngqo ngalesi simo. Idatha yokuhlolwa komtholampilo yabonisa ukuthi i-inebilizumab yehlisa ingozi yokuphindeka kwe-NMOSD ngamaphesenti angama-73% uma iqhathaniswa ne-placebo.

I-Rituximab, ngenkathi isetshenziswa kakhulu ku-NMOSD, inikezwa "ngaphandle kwelebula" ngalesi simo. Kodwa-ke, isetshenziswe ku-NMOSD iminyaka eminingi futhi ineprofile yokuphepha esungulwe kahle. Abanye odokotela bakhetha i-rituximab ngenxa yesipiliyoni sabo esibanzi ngayo.

Amashejuli okulinganisa ahlukile phakathi kwale mithi. I-Inebilizumab inikezwa njalo ezinyangeni eziyisithupha ngemuva kwemithamo yokuqala emibili, ngenkathi i-rituximab inganikezwa kaningi ekuqaleni, bese ihlukaniswa njalo ezinyangeni eziyisithupha kuya kweziyishumi nambili kuye ngempendulo yakho.

Izindleko nokuhlinzekwa komshuwalense nakho kungaba nendima ekwenzeni isinqumo. Ithimba lakho lezempilo lizosebenza nawe ukunquma ukuthi iyiphi imithi efaneleka kakhulu ngokusekelwe emlandweni wakho wezokwelapha, okuthandayo, kanye nezinto ezibhekelwayo ezingokoqobo njengokuhlinzekwa komshuwalense.

Imibuzo Evame Ukubuzwa Mayelana ne-Inebilizumab

Ingabe i-Inebilizumab iphephile kubantu abanezifo ezinye ze-autoimmune?

Uma unezinye izimo ze-autoimmune ezifana ne-rheumatoid arthritis noma i-multiple sclerosis, i-inebilizumab ingase isaba yindlela, kodwa idinga ukuhlolwa ngokucophelela. Udokotela wakho uzocabangela ukuthi i-inebilizumab ingase ihlangane kanjani nezinye izimo zakho nemithi yakho.

Ukuba nezimo eziningi ze-autoimmune ngezinye izikhathi kungenza ukwelashwa kube nzima kakhulu, kodwa akusho ngokushesha ukuthi i-inebilizumab ngeke isetshenziswe. Ithimba lakho lezempilo lizohlola izinzuzo zokwelapha i-NMOSD yakho ngokumelene nanoma yiziphi izingozi ezingase zibe khona kwezinye izimo zakho.

Abanye abantu empeleni bathola ukuthi i-inebilizumab iyasiza ngezinye izimpawu ze-autoimmune, njengoba amaseli e-B edlala indima ezinqubweni ezihlukahlukene ze-autoimmune. Kodwa-ke, lokhu akuqinisekisiwe, futhi umuthi uvunyelwe ngokuqondile kuphela i-NMOSD.

Ngingenzani uma ngiphuthelwa ngengozi umthamo we-Inebilizumab?

Uma uphuthelwa ukufakwa kwe-inebilizumab okuhleliwe, xhumana nomhlinzeki wakho wezempilo ngokushesha ngangokunokwenzeka ukuze uhlele kabusha. Ngokungafani nemithi yansuku zonke, ukuphuthelwa ukuqokwa kokufakwa akudali inhlekelele ngokushesha, kodwa kubalulekile ukugcina isimiso sakho sokwelashwa.

Udokotela wakho angase ancome ukuthola umthamo ophuthelwe ngokushesha ngangokunokwenzeka, noma angase alungise isimiso sakho ngokusekelwe ukuthi sekunesikhathi esingakanani kusukela ekufakweni kwakho kokugcina. Umuthi uhlala ohlelweni lwakho izinyanga eziningana, ngakho-ke ngokuvamile kukhona ukuguquguquka okuthile ngesikhathi.

Ungazami ukuphinda imithamo noma ushintshe isimiso sakho ngaphandle kokubonisana nethimba lakho lezempilo. Bazokusiza ukuthi ubuyele emgwaqeni ngohlelo lwakho lokwelapha ngendlela ephephe kunazo zonke.

Ngingenzani uma ngizwa imiphumela emibi ngesikhathi sokufakwa?

Uma uhlangabezana nanoma yiziphi izimpawu ezikhathazayo ngesikhathi sokufakwa kwe-inebilizumab, yazisa umhlengikazi wakho noma umhlinzeki wakho wezempilo ngokushesha. Izikhungo zokufakwa zihlome kahle ukubhekana nokusabela, futhi abasebenzi baqeqeshwe ukusabela ngokushesha.

Ukusabela okuvamile kokufakwa njengomkhuhlane olula, ama-chills, noma ukuluma ngokuvamile kungalawulwa ngokunciphisa izinga lokufakwa noma ukunikeza imithi eyengeziwe ngaphambi kokwelashwa. Ukusabela okukhulu kungenzeka kudingeke ukuthi kumiswe ukufakwa okwesikhashana noma unomphela.

Ithimba lakho lezempilo lizoba nemithi ephuthumayo etholakalayo uma idingeka, okuhlanganisa ama-antihistamines, ama-corticosteroids, kanye ne-epinephrine. Ukusabela okuningi kokufakwa kulawuleka futhi akuvimbeli abantu ekuqhubekeni nokwelashwa.

Ngingayeka nini ukuthatha i-Inebilizumab?

Isinqumo sokuyeka i-inebilizumab kufanele senziwe ngaso sonke isikhathi ngokubonisana nethimba lakho lezempilo. Abantu abaningi abane-NMOSD badinga ukwelashwa kwesikhathi eside ukuvimbela ukuphindeka, futhi ukuyeka imithi ngokuvamile kuholela ekubuyeni komsebenzi wesifo.

Udokotela wakho angase acabange ukuyeka noma ukushintsha ukwelashwa kwakho uma uhlangabezana nemiphumela emibi engaphezu kwezinzuzo, uma isifo sakho sihlala sizinzile isikhathi eside kakhulu, noma uma izinketho zokwelashwa ezingcono zitholakala.

Abanye abantu bangase bakwazi ukushintshela emuthini ohlukile kunokuyeka ukwelashwa ngokuphelele. Lesi sinqumo sincike ekuphenduleni kwakho ngakunye ekwelashweni kanye nesimo sempilo esiphelele.

Ngingakwazi yini ukuthola imithi yokugoma ngenkathi ngithatha i-Inebilizumab?

Ukugoma ngenkathi uthatha i-inebilizumab kudinga ukucatshangelwa okukhethekile ngoba umuthi uthinta amasosha akho omzimba. Akufanele uthole imithi yokugoma ephilayo ngenkathi uthatha i-inebilizumab, njengoba ingase ibangele ukutheleleka.

Imithi yokugoma engasebenzi njengomjovo we-flu noma imithi yokugoma ye-COVID-19 ngokuvamile iphephile, kodwa ingase ingasebenzi njengoba ingaba kumuntu onamasosha omzimba asebenza ngokugcwele. Udokotela wakho uzoncoma isikhathi esingcono sokugoma.

Ngokuvamile kungcono ukuthola imigomo edingekayo ngaphambi kokuqala i-inebilizumab uma kungenzeka. Ithimba lakho lokunakekelwa kwezempilo lizokwenza uhlelo lokugoma olukugcina uvikelekile ngenkathi kuncishiswa noma yiziphi izingozi ezivela ekwelashweni kwakho.